This FAQ explains recent FDA approvals for acne vulgaris, the common form of acne with blackheads, whiteheads, and inflamed pimples. The biggest change is OTC Epiduo-strength gel for ages 12 and older; other newer drugs remain prescription-only. Galderma said the FDA approved Differin Epiduo Gel for OTC use on May 22, 2026 Galderma approval announcement. The gel combines adapalene 0.1% with benzoyl peroxide 2.5% for acne vulgaris in patients 12 and older.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Explore the official data from FDA — Use this primary source to review the underlying data.
- Read the official guidance from Bauschhealth — Use this primary source to verify the official guidance.
Table of Contents
- What can you buy without a prescription?
- Which combination topicals still need a prescription?
- What about hormone-targeting cream and acne pills?
- Who qualifies, and what limits matter?
What can you buy without a prescription?
Epiduo-strength adapalene plus benzoyl peroxide moved from prescription to OTC. Shoppers 12 and older can now pick it without a clinician visit. The switch covers the same strength previously sold by prescription.
Use it only as the package directs for acne vulgaris. Do not use it for children under 12. Talk with a pharmacist if you use other acne topicals, have very sensitive skin, or are unsure the diagnosis is acne vulgaris.
Which combination topicals still need a prescription?
Bausch Health said the FDA approved Cabtreo gel on Oct. 20, 2023 for acne vulgaris in patients 12 and older Bausch Health announcement. Cabtreo is a fixed-dose triple mix of clindamycin phosphate 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1%.
It is applied as a thin layer once daily, for topical use only. Sol-Gel reported FDA approval of Twyneo cream on July 27, 2021 for adults and children 9 and older. Twyneo pairs tretinoin 0.1% with benzoyl peroxide 3% in one product. Silica microencapsulation keeps the two ingredients separate in the cream until use.
What about hormone-targeting cream and acne pills?
Cassiopea received FDA approval for Winlevi cream 1% on Aug. 26-27, 2020 for acne vulgaris in patients 12 and older BioSpace report on Cassiopea's approval. Winlevi contains clascoterone 1%, a topical androgen-receptor inhibitor. It targets hormonal signaling in skin rather than bacteria or clogged pores alone.
Paratek and Almirall reported FDA approval of sarecycline, sold as Seysara, on Oct. 1-2, 2018. It is a once-daily oral narrow-spectrum tetracycline-derived antibiotic. It treats inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 and older.
Who qualifies, and what limits matter?
Approvals set firm age and use limits. The FDA Cabtreo label directs once-daily thin-layer topical use in patients 12 and older FDA Cabtreo label.
Twyneo must not be used after a serious hypersensitivity reaction to benzoyl peroxide or any component. Winlevi can cause itching, burning, redness, or peeling. Check these points before you buy or ask for a prescription: Match severity, pregnancy plans, and antibiotic history with a clinician when a prescription product is needed.
- Age: 12 and older for Epiduo OTC, Cabtreo, and Winlevi; 9 and older for Twyneo and Seysara.
- Route: Cabtreo is topical only; do not swallow it or apply thick layers.
- History: avoid Twyneo if benzoyl peroxide caused serious allergy symptoms before.
- Tolerance: reduce frequency or stop Winlevi and seek care if irritation is strong or peeling spreads.